Pharma News

A new strategy that focuses on targeting "hot zones" - areas where the risk of HIV infection is much higher than the national average - can help stop the spread of the virus in Africa, scientists say. Globally, more than 34 million people are infected with HIV; in sub-Saharan Africa alone, 3 million new infections occur annually. In an attempt to stop the spread of HIV, governments in the region are considering providing antiretroviral drugs to people who do not have the virus but are at risk for becoming infected, researchers said. Such drugs are known as pre-exposure prophylaxis, or PrEP.

Toxic mushrooms may hold secrets to tackling deadly diseases such as cancer, according to a new research. A team of Michigan State University scientists has discovered an enzyme that is the key to the lethal potency of poisonous mushrooms.

Researchers have identified a network of genes that appear to work together in determining alcohol dependence. By comparing patterns of genetic code from the brain tissue of alcoholics and nonalcoholics, researchers discovered a particular set of genes co-expressed together in the individuals who had consumed the most alcohol.

Human ancestors began evolving the ability to digest alcohol about 10 million years ago, researchers say. The study found that a single genetic mutation 10 million years ago endowed human ancestors with an enhanced ability to break down ethanol.

Vitamin D supplements can reduce chronic obstructive pulmonary disease (COPD) flare-ups by over 40 per cent in patients with a vitamin D deficiency, according to a new research. Researchers from Queen Mary University of London conducted a randomised trial on 240 patients with COPD in and around London. Half of the patients (122) received vitamin D supplements and the other half (118) received an equivalent placebo.